Singapore markets closed

scPharmaceuticals Inc. (2SX.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
4.6000+0.0800 (+1.77%)
As of 03:03PM CET. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 167.76M
Enterprise value 134.76M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)13.87
Price/book (mrq)4.74
Enterprise value/revenue 9.91
Enterprise value/EBITDA -2.93

Trading information

Stock price history

Beta (5Y monthly) 0.07
52-week change 3-46.19%
S&P500 52-week change 329.57%
52-week high 311.2000
52-week low 34.3600
50-day moving average 34.9786
200-day moving average 35.9527

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 536.05M
Implied shares outstanding 637.12M
Float 818.32M
% held by insiders 16.59%
% held by institutions 175.87%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-250.28%

Management effectiveness

Return on assets (ttm)-31.67%
Return on equity (ttm)-99.97%

Income statement

Revenue (ttm)13.59M
Revenue per share (ttm)0.35
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -55.37M
Net income avi to common (ttm)-54.81M
Diluted EPS (ttm)-1.3100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)76.99M
Total cash per share (mrq)2.13
Total debt (mrq)40.27M
Total debt/equity (mrq)108.20%
Current ratio (mrq)7.08
Book value per share (mrq)1.03

Cash flow statement

Operating cash flow (ttm)-59.24M
Levered free cash flow (ttm)-40.4M